**This article has been corrected:** A line in the Abstract section has been corrected to read, "CTEN overexpression was detected in GC cell lines (2/5 cell lines; 40%) and primary AEG tumor samples (69/104 cases; 66%)." The data in the main document and Table 1, Figure 2A remains correct. The authors declare that these corrections do not change the results or conclusions of this paper.

ABSTRACT {#s1}
========

**Background:** To detect a novel treatment target for adenocarcinoma of the esophagogastric junction (AEG), we tested whether C-terminal tensin-like (CTEN), a member of the tensin gene family and frequently overexpressed in various cancers, acts as a cancer-promoting gene through overexpression in AEG.

**Materials and Methods:** We analyzed 5 gastric adenocarcinoma (GC) cell lines and 104 primary AEG tumors curatively resected in our hospital between 2000 and 2010.

**Results:** CTEN overexpression was detected in GC cell lines (2/5 cell lines; 40%) and primary AEG tumor samples (69/104 cases; 66%). CTEN knockdown using several specific siRNAs inhibited the proliferation, migration, and invasion of CTEN-overexpressing cells. CTEN overexpression was significantly correlated with more aggressive venous and lymphatic invasion, deeper tumor depth, and higher rates of lymph node metastasis and recurrence. Patients with CTEN-overexpressing tumors had a worse overall rate of survival than those with non-expressing tumors (*P* \< 0.0001, log-rank test) in an expression-dependent manner. CTEN positivity was independently associated with a worse outcome in the multivariate analysis (*P* = 0.0423, hazard ratio 3.54 \[1.04--16.4\]).

**Conclusions:** CTEN plays a crucial role in tumor cell proliferation, migration, and invasion through its overexpression, which highlights its usefulness as a prognosticator and potential therapeutic target in AEG.
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